Health Care & Hospital Law,
Administrative/Regulatory,
9th U.S. Circuit Court of Appeals
Mar. 25, 2020
9th Circuit says FDA should disclose why it allowed drug to treat Ebola
In a case that could affect how government regulators disclose their decisions on possible coronavirus treatments, a 9th U.S. Circuit Court of Appeals panel on Tuesday overturned an Arizona federal judge's order allowing the Food and Drug Administration to withhold records on an experimental drug used to treat the Ebola virus years ago.
In a case that could affect how government regulators disclose their decisions on possible coronavirus treatments, a 9th U.S. Circuit Court of Appeals panel on Tuesday overturned an Arizona federal judge's order allowing the Food and Drug Administration to withhold records on an experimental drug used to treat the Ebola virus years ago.
The FDA rejected Arizona-based Goldwater Institute's Freedom of Information Act request for...
For only $95 a month (the price of 2 article purchases)
Receive unlimited article access and full access to our archives,
Daily Appellate Report, award winning columns, and our
Verdicts and Settlements.
Or
$795 for an entire year!
Or access this article for $45
(Purchase provides 7-day access to this article. Printing, posting or downloading is not allowed.)
Already a subscriber?
Sign In